Norsed (Risedronate Sodium)

Risedronate Sodium binds to hydroxyapatite at sites of active bone remodeling and inhibits the enzyme farnesyl pyrophosphate synthase in osteoclasts. This suppression reduces osteoclast activity, decreasing bone resorption and allowing bone formation to predominate, which strengthens skeletal tissue.

The dose of Norsed is determined by the prescribing healthcare professional based on the patient’s specific condition, renal function, calcium and vitamin D status, and overall treatment goals. Dosage regimens are individualized and should follow the prescriber’s instructions.

The safety of Risedronate Sodium in pregnancy and lactation has not been established. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and only under medical supervision.

To order Norsed, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Norsed (Risedronate Sodium) is a nitrogen‑containing bisphosphonate similar to alendronate and ibandronate in its mechanism of inhibiting osteoclasts. Compared with some alternatives, risedronate is often administered once weekly, offering a convenient dosing schedule while maintaining comparable efficacy in increasing bone density.

Norsed should be stored at ambient temperature, below 25 °C, in its original packaging. The container should be kept dry and protected from moisture and direct sunlight to maintain product stability throughout its shelf life.

Norsed is taken orally, usually with a full glass of plain water. Patients are advised to swallow the tablet whole, avoid lying down for at least 30 minutes after ingestion, and not to take it with food, mineral supplements, or antacids that could interfere with absorption.

Serious risks include osteonecrosis of the jaw, atypical femur fractures, severe allergic reactions, and esophageal ulceration. These events are rare but require immediate medical attention if symptoms such as jaw pain, unusual thigh pain, swelling, or difficulty swallowing occur.

Norsed is contraindicated in patients with known hypersensitivity to risedronate or other bisphosphonates, those with severe renal impairment, and individuals with esophageal disorders that delay tablet passage. Caution is also advised for patients with low calcium levels or active dental problems.